Literature DB >> 12694490

Characteristics of superficial mycoses in Malta.

Loranne Vella Zahra1, Paul Gatt, Michael J Boffa, Eileen Borg, Edwin Mifsud, Lawrence Scerri, Dino Vella Briffa, Joseph L Pace.   

Abstract

BACKGROUND: A study was conducted to determine the chief agents of superficial mycoses in Malta. Data were collected over a 5-year period from mycologic investigations carried out on all dermatologic specimens sent to the Mycology Laboratory at St. Luke's Hospital in Malta.
METHODS: In the period between January 1995 and December 1999, a total of 1271 specimens from skin, nails, or hair were collected from 1200 clinically suspected cases of dermatomycoses.
RESULTS: The fungi cultivated included dermatophytes (n = 371), yeasts (n = 33), and nondermatophyte filamentous fungi (n = 12). Trichophyton rubrum (n = 121) was the most prevalent, followed by Microsporum canis (n = 109), T. mentagrophytes (n = 80), M. gypseum (n = 27), Epidermophyton floccosum (n = 17), T. soudanense (n = 10), T. tonsurans (n = 2), T. verrucosum (n = 2), M. persicolor (n = 1), and T. violaceum (n = 1). Candida species were also cultivated, with C. parapsilosis (n = 14) being the most common, followed by C. albicans (n = 12) and C. tropicalis (n = 6). Nondermatophyte filamentous fungi were isolated from nail specimens only.
CONCLUSIONS: In this study, superficial fungal infections were reported more commonly in female (n = 207) than in male (n = 182) patients. M. canis was the chief agent of tinea capitis and tinea corporis, whilst T. rubrum was the main causative agent of tinea pedis, tinea manuum, and tinea unguium. Onychomycosis due to Candida species was more common in female than in male patients.

Entities:  

Mesh:

Year:  2003        PMID: 12694490     DOI: 10.1046/j.1365-4362.2003.01789.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  11 in total

1.  Human Infections with Microsporum gypseum Complex (Nannizzia gypsea) in Slovenia.

Authors:  Mateja Dolenc-Voljč; Jurij Gasparič
Journal:  Mycopathologia       Date:  2017-08-24       Impact factor: 2.574

2.  [Tinea faciei caused by Nannizzia persicolor : An underdiagnosed dermatophyte?]

Authors:  M Metzner; T Schwarz; J Brasch
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

3.  Analysis of dermatomycoses in Lanzhou district of northwestern China.

Authors:  Niu Tao-Xiang; Luo Zhi-Cheng; Wu Sao-Mao; Li Wen-Zhu
Journal:  Mycopathologia       Date:  2005-11       Impact factor: 2.574

Review 4.  The Changing Face of Dermatophytic Infections Worldwide.

Authors:  Ping Zhan; Weida Liu
Journal:  Mycopathologia       Date:  2016-10-25       Impact factor: 2.574

5.  Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.

Authors:  Chhavi Gupta; Marit Jongman; Shukla Das; K Snehaa; S N Bhattacharya; S Seyedmousavi; Anne D van Diepeningen
Journal:  Mycopathologia       Date:  2016-05-02       Impact factor: 2.574

Review 6.  Candidal onychomycosis: a mini-review.

Authors:  J A M S Jayatilake; W M Tilakaratne; G J Panagoda
Journal:  Mycopathologia       Date:  2009-05-31       Impact factor: 2.574

7.  Onychomycosis in qassim region of saudi arabia: a clinicoaetiologic correlation.

Authors:  Muhammad Shahzad; Abdullateef A Alzolibani; Ahmad A Al Robaee; Ghada A Bin Saif; Ibrahim H K Babikir; Eltuhami M Abdel-Magied; Abeer E Elsayed
Journal:  J Clin Diagn Res       Date:  2014-08-20

8.  Dermatomycosis frequency and localization sites.

Authors:  Allma Ferizi Koçinaj; Merita Grajqevci Kotori; Andi Koraqi; Monika Fida
Journal:  Med Arch       Date:  2015-02-21

9.  Epidemiological status of dermatophytosis in Guilan, north of Iran.

Authors:  A A Fallahi; A Rezaei-Matehkolaei; S Rezaei
Journal:  Curr Med Mycol       Date:  2017-03

10.  Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis.

Authors:  Felix Fich; Alvaro Abarzúa-Araya; Mario Pérez; Yalile Nauhm; Eugenia León
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.